Nxera Pharma Co., Ltd. ( SOLTF) - Key Metrics
SOLTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $83.16 | -$2.19 | $61.16 | $60.59 |
| 2026Q1 | $125.17 | $19.94 | -$18.39 | -$21.77 |
| 2025Q4 | $86.07 | -$85.56 | -$1.39 | -$3.01 |
| 2025Q3 | $75.71 | -$18.74 | -$33.36 | -$34.50 |
| 2025Q2 | $93.67 | -$26.35 | -$2 | -$2.99 |
SOLTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -117.64 |
| 2026Q1 | 0% | 10.93 |
| 2025Q4 | 0% | -2.49 |
| 2025Q3 | 0% | -13.13 |
| 2025Q2 | 0% | -9.02 |
SOLTF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 5.85% | 0% |
| 2026Q1 | -2.60% | 0% |
| 2025Q4 | -0.35% | 0% |
| 2025Q3 | -3.65% | 0% |
| 2025Q2 | -0.31% | 0% |
SOLTF
Price: $5.01
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.56 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 457.8 million